The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus

Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study

(2021) Tak Kyu Oh et al.   ACTA DIABETOLOGICA

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

(2021) Matthieu Wargny et al.   DIABETOLOGIA

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

(2020) Pan Luo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

(2020) Lihua Zhu et al.   Cell Metabolism

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

(2020) Yuchen Chen et al.   DIABETES CARE

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

(2020) Bertrand Cariou et al.   DIABETOLOGIA

Metformin, neutrophils and COVID-19 infection

(2020) Rinkoo Dalan   DIABETES RESEARCH AND CLINICAL PRACTICE

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

(2020) Inés Valencia et al.   Frontiers in Pharmacology

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

(2020) Naomi Holman et al.   Lancet Diabetes & Endocrinology

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

(2020) Xu Cheng et al.   Cell Metabolism

Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report

(2020) Yongchao Gao et al.   CTS-Clinical and Translational Science

Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2

(2020) Michelle Lally et al.   Journal of the American Medical Directors Association

Diabetes, infection risk and COVID-19

(2020) Suheda Erener   Molecular Metabolism

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

(2020) Luis M. Pérez-Belmonte et al.   BMC Medicine

Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study

(2020) Nan Jiang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy

(2019) Rosina Pryor et al.   CELL

MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?

(2019) Michael A Nauck et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?

(2018) Mark Schuiveling et al.   CURRENT DRUG TARGETS

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

(2017) Hao Wu et al.   NATURE MEDICINE

Metformin extends C. elegans lifespan through lysosomal pathway

(2017) Jie Chen et al.   eLife

Metformin Activates AMPK through the Lysosomal Pathway

(2016) Chen-Song Zhang et al.   Cell Metabolism

Acute kidney injury from SGLT2 inhibitors: potential mechanisms

(2016) Kai Hahn et al.   Nature Reviews Nephrology

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2

(2014) W. De Haes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metformin and cancer

(2013) Christos V. Rizos et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice

(2012) Jiejie Li et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR